Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ACADIA PHARMACEUTICALS via ACADIA PHARMACEUTICALS
2026 · third_quarter · Q3
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Source: Senate LDA
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
Mikaela Naylon Give Kids a Chance Act
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Mikaela Naylon Give Kids a Chance Act
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Mikaela Naylon Give Kids a Chance Act
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Accelerating Kids’ Access to Care Act of 2025
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Accelerating Kids’ Access to Care Act of 2025
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Accelerating Kids’ Access to Care Act of 2025
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Accelerating Kids’ Access to Care Act of 2025
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Accelerating Kids’ Access to Care Act of 2025
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Accelerating Kids’ Access to Care Act of 2025
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
BINSA Act, H.R. 9102.
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
BINSA Act, H.R. 9102.
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Accelerating Kids’ Access to Care Act
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Accelerating Kids’ Access to Care Act
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Accelerating Kids’ Access to Care Act
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Accelerating Kids’ Access to Care Act
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Accelerating Kids’ Access to Care Act
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Accelerating Kids’ Access to Care Act
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Wilson's Creek National Battlefield Boundary Revision Act of 2021
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Wilson's Creek National Battlefield Boundary Revision Act of 2021
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Wilson's Creek National Battlefield Boundary Revision Act of 2021
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Smarter Approaches to Nuclear Expenditures Act
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Smarter Approaches to Nuclear Expenditures Act
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Smarter Approaches to Nuclear Expenditures Act
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Smarter Approaches to Nuclear Expenditures Act
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Smarter Approaches to Nuclear Expenditures Act
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Smarter Approaches to Nuclear Expenditures Act
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Consolidation Prevention and Competition Promotion Act of 2021
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Consolidation Prevention and Competition Promotion Act of 2021
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Consolidation Prevention and Competition Promotion Act of 2021
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Orphan Cures Act (HR 946, S 1862), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Accelerating Kids Access to Care Act (HR 1509, S 752).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, Issues related to protecting patient access to medicines in Medicare, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Orphan Cures Act (HR 946, S 1862), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Accelerating Kids Access to Care Act (HR 1509, S 752).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
Mikaela Naylon Give Kids a Chance Act
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, Orphan Cures Act (HR 946, S 1862), Give Kids A Chance (HR 1262, S 932), Cameron's Law (HR 1414), Accelerating Kids Access to Care Act (HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930).
Mikaela Naylon Give Kids a Chance Act
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, Orphan Cures Act (HR 946, S 1862), Give Kids A Chance (HR 1262, S 932), Cameron's Law (HR 1414), Accelerating Kids Access to Care Act (HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930).
Mikaela Naylon Give Kids a Chance Act
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Mikaela Naylon Give Kids a Chance Act
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022; Orphan Cures Act (HR 946); National Plan to End Parkinsons Act (Public Law 118-66, 118th Congress); Give Kids A Chance (HR1262); Cameron's Law (HR1414).
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
Implementation of the Inflation Reduction Act of 2022, Orphan Cures Act (HR 946, S 1862), Give Kids A Chance (HR 1262, S 932), Cameron's Law (HR 1414), Accelerating Kids Access to Care Act (HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930).
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
Implementation of the Inflation Reduction Act of 2022; Orphan Cures Act (HR 946); National Plan to End Parkinsons Act (Public Law 118-66, 118th Congress); Give Kids A Chance (HR1262); Cameron's Law (HR1414).
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Implementation of the Inflation Reduction Act of 2022, Orphan Cures Act (HR 946, S 1862), Give Kids A Chance (HR 1262, S 932), Cameron's Law (HR 1414), Accelerating Kids Access to Care Act (HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930).
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Orphan Cures Act (HR 946, S 1862), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Accelerating Kids Access to Care Act (HR 1509, S 752).
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, Issues related to protecting patient access to medicines in Medicare, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Orphan Cures Act (HR 946, S 1862), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Accelerating Kids Access to Care Act (HR 1509, S 752).
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022; Issues related to protecting patient access to medicines in Medicare; Issues related to access to medicines for Parkinson's disease patients; Issues related to Antipsychotic use in Medicare; Orphan Cures Act (HR 946); National Plan to End Parkinsons Act (Public Law 118-66, 118th Congress); EPIC Act (HR 1492).
Accelerating Kids’ Access to Care Act of 2025
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Accelerating Kids’ Access to Care Act of 2025
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Accelerating Kids’ Access to Care Act of 2025
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, Orphan Cures Act (HR 946, S 1862), Give Kids A Chance (HR 1262, S 932), Cameron's Law (HR 1414), Accelerating Kids Access to Care Act (HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930).
Accelerating Kids’ Access to Care Act of 2025
Client: ACADIA PHARMACEUTICALS · Firm: ACADIA PHARMACEUTICALS
Implementation of the Inflation Reduction Act of 2022, Orphan Cures Act (HR 946, S 1862), Give Kids A Chance (HR 1262, S 932), Cameron's Law (HR 1414), Accelerating Kids Access to Care Act (HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930).
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
BINSA Act, H.R. 9102.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
ACADIA PHARMACEUTICALS via ACADIA PHARMACEUTICALS
2026 · second_quarter · Q2
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
BINSA Act, H.R. 9102.
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
ACADIA PHARMACEUTICALS via ACADIA PHARMACEUTICALS
2026 · first_quarter · Q1
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
ACADIA PHARMACEUTICALS via ACADIA PHARMACEUTICALS
2025 · fourth_quarter · Q4
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
ACADIA PHARMACEUTICALS via ACADIA PHARMACEUTICALS
2025 · third_quarter · Q3
Implementation of the Inflation Reduction Act of 2022, Orphan Cures Act (HR 946, S 1862), Give Kids A Chance (HR 1262, S 932), Cameron's Law (HR 1414), Accelerating Kids Access to Care Act (HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930).
Implementation of the Inflation Reduction Act of 2022, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Orphan Cures Act (HR 946, S 1862), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Accelerating Kids Access to Care Act (HR 1509, S 752).
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADIA PHARMACEUTICALS via ACADIA PHARMACEUTICALS
2025 · second_quarter · Q2
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
Implementation of the Inflation Reduction Act of 2022, Orphan Cures Act (HR 946, S 1862), Give Kids A Chance (HR 1262, S 932), Cameron's Law (HR 1414), Accelerating Kids Access to Care Act (HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930).
Implementation of the Inflation Reduction Act of 2022, Issues related to protecting patient access to medicines in Medicare, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Orphan Cures Act (HR 946, S 1862), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Accelerating Kids Access to Care Act (HR 1509, S 752).
ACADIA PHARMACEUTICALS via ACADIA PHARMACEUTICALS
2025 · first_quarter · Q1
Implementation of the Inflation Reduction Act of 2022; Orphan Cures Act (HR 946); National Plan to End Parkinsons Act (Public Law 118-66, 118th Congress); Give Kids A Chance (HR1262); Cameron's Law (HR1414).
Implementation of the Inflation Reduction Act of 2022; Issues related to protecting patient access to medicines in Medicare; Issues related to access to medicines for Parkinson's disease patients; Issues related to Antipsychotic use in Medicare; Orphan Cures Act (HR 946); National Plan to End Parkinsons Act (Public Law 118-66, 118th Congress); EPIC Act (HR 1492).
ACADIA PHARMACEUTICALS via ACADIA PHARMACEUTICALS
2024 · fourth_quarter · Q4
Issues related to the Orphan Drug Tax Credit.
Implementation of the Inflation Reduction Act of 2022; Issues related to protecting patient access to medicines in Medicare; Issues related to access to medicines for Parkinson's disease patients; Issues Related to Antipsychotic use in Medicaid (HR 4096); Orphan Cures Act (HR 5539 / S 3131); National Plan to End Parkinson's Act (HR 2365 / S 1064); Protect Rare Act (HR 6094); EPIC Act (HR 7174); BIOSECURE Act (HR 7085); The Mini Act (HR 5547 / S 476).
Implementation of the Inflation Reduction Act of 2022; Issues Related to the Orphan Drug Tax Credit; Help Copays Act (HR 830 / S 1375); Orphan Cures Act (HR 5539 / S 3131); National Plan to End Parkinson's Act (HR 2365 / S 1064); Protect Rare Act (HR 6094); The Creating Hope Reauthorization Act (HR 7384 / S 4583) / HR 3433); BIOSECURE Act (HR 7085); The American Recovery Act (HR 10545).
ACADIA PHARMACEUTICALS via ACADIA PHARMACEUTICALS
2024 · third_quarter · Q3
BIOSECURE Act (HR 7085).
Implementation of the Inflation Reduction Act of 2022; Help Copays Act (HR 830 / S 1375); Orphan Cures Act (HR 5539 / S 3131); National Plan to End Parkinson's Act (HR 2365 / S 1064); Protect Rare Act (HR 6094); The Creating Hope Reauthorization Act (HR 7384 / S 4583) / HR 3433); BIOSECURE Act (HR 7085).
Implementation of the Inflation Reduction Act of 2022; Issues related to protecting patient access to medicines in Medicare; Issues related to access to medicines for Parkinson's disease patients; Issues Related to Antipsychotic use in Medicaid (HR 4096); Orphan Cures Act (HR 5539 / S 3131); National Plan to End Parkinson's Act (HR 2365 / S 1064); Protect Rare Act (HR 6094); EPIC Act (HR 7174); BIOSECURE Act (HR 7085).
ACADIA PHARMACEUTICALS via ACADIA PHARMACEUTICALS
2024 · second_quarter · Q2
Implementation of the Inflation Reduction Act of 2022; Help Copays Act (HR 830 / S 1375); Orphan Cures Act (HR 5539 / S 3131); National Plan to End Parkinson's Act (HR 2365 / S 1064); Protect Rare Act (HR 6094); The Creating Hope Reauthorization Act (HR 7384 / S 4583); Protecting and Preserving Social Security Act (S 4583).
Implementation of the Inflation Reduction Act of 2022; Issues related to protecting patient access to medicines in Medicare; Issues related to access to medicines for Parkinson's disease patients; Issues Related to Antipsychotic use in Medicaid (HR 4096); Orphan Cures Act (HR 5539 / S 3131); National Plan to End Parkinson's Act (HR 2365 / S 1064); Protect Rare Act (HR 6094); EPIC Act (HR 7174).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADIA PHARMACEUTICALS via ACADIA PHARMACEUTICALS
2024 · first_quarter · Q1
Implementation of the Inflation Reduction Act of 2022; Help Copays Act (HR 830 / S. 1375); Orphan Cures Act (HR 5539 / S. 3131); National Plan to End Parkinson's Act (HR 2365 / S. 1064); Protect Rare Act (HR 6094); The Creating Hope Act (HR 7384).
Implementation of the Inflation Reduction Act of 2022; Issues related to protecting patient access to medicines in Medicare; Issues related to access to medicines for Parkinson's disease patients; Issues Related to Antipsychotic use in Medicaid (HR 4096); Orphan Cures Act (HR 5539 / S. 3131); National Plan to End Parkinson's Act (HR 2365 / S. 1064); Protect Rare Act (HR 6094); EPIC Act (HR 7174).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADIA PHARMACEUTICALS via ACADIA PHARMACEUTICALS
2023 · fourth_quarter · Q4
Implementation of the Inflation Reduction Act of 2022; Help Copays Act (HR 830 / S. 1375); Orphan Cures Act (HR 5539); Issues related to rare disease research incentives; National Plan to End Parkinson's Act (HR 2365 / S. 1064); Protect Rare Act (HR 6094).
Implementation of the Inflation Reduction Act of 2022; Six Protected Classes: Issues related to protecting patient access to medicines in Medicare; Nursing Home Quality: Issues related to access to medicines for Parkinson's disease patients; HR 4096 - Issues Related to Antipsychotic use in Medicaid; HR 5539 - Orphan Cures Act; HR 2365 / S. 1064 - National Plan to End Parkinson's Act; HR 6094 - Protect Rare Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADIA PHARMACEUTICALS via ACADIA PHARMACEUTICALS
2023 · third_quarter · Q3
Drug Pricing: Implementation of the Inflation Reduction Act of 2022; Protected Classes: Issues related to protecting patient access to medicines in Medicare; Nursing Home Quality: Issues related to medicines in nursing homes; HR 4096 - Issues Related to Antipsychotic use in Medicaid; HR 5539 - Orphan Cures Act; HR 2365 / S. 1064 - National Plan to End Parkinson's Act.
Drug Pricing: Implementation of the Inflation Reduction Act of 2022; Help Copays Act (H.R. 830 / S. 1375); Orphan Cures Act (H.R. 5539); Issues related to rare disease research incentives; National Plan to End Parkinson's Act (H.R. 2365 / S. 1064).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADIA PHARMACEUTICALS via ACADIA PHARMACEUTICALS
2023 · second_quarter · Q2
Drug Pricing: Implementation of the Inflation Reduction Act of 2022; Help Copays Act (H.R. 830).
Drug Pricing: Implementation of the Inflation Reduction Act of 2022; Six Protected Classes: Issues related to protecting patient access to medicines in Medicare; Nursing Home Quality: Issues related to medicines in nursing homes; HR 4096; Issues Related to Antipsychotic use in Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADIA PHARMACEUTICALS via ACADIA PHARMACEUTICALS
2023 · first_quarter · Q1
Drug Pricing: Implementation of the Inflation Reduction Act of 2022; Six Protected Classes: Issues related to protecting patient access to medicines in Medicare; Nursing Home Quality: Issues related to medicines in nursing homes.
Drug Pricing: Implementation of the Inflation Reduction Act of 2022.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADIA PHARMACEUTICALS via ACADIA PHARMACEUTICALS
2022 · fourth_quarter · 4A
Rett Syndrome Research: H.R. 8236 Department of Defense Appropriations Act, 2023
Drug pricing issues: H.R. 5376, Inflation Reduction Act of 2022; Neurology Research: S. 4661 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2023; Rett Syndrome Research: H.R. 8236 Department of Defense Appropriations Act, 2023; Parkinson's Plan: S. 4851, National Plan to End Parkinsons Act; H.R.2617 - Consolidated Appropriations Act, 2023, 117th Congress (2021-2022)
Nursing Home Quality: S. 4659 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023; Neurology Research: S. 4661 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2023; Rett Syndrome Research: H.R. 8236, Department of Defense Appropriations Act, 2023; H.R.2617 - Consolidated Appropriations Act, 2023, 117th Congress (2021-2022)
ACADIA PHARMACEUTICALS via ACADIA PHARMACEUTICALS
2022 · fourth_quarter · Q4
Nursing Home Quality: S. 4659 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023; Neurology Research: S. 4661 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2023; Rett Syndrome Research: H.R. 8236, Department of Defense Appropriations Act, 2023; Consolidated Appropriations Act, 2023: H.R.216
Drug Pricing Issues: H.R. 5376, Inflation Reduction Act of 2022; Nursing Home Quality: S. 4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023; Parkinson's Plan: S. 4851, National Plan to End Parkinsons Act; Six Protected Classes resolution: H. Res. 1390, Expressing support for the protection of Medicare part D's six protected classes
ACADIA PHARMACEUTICALS via ACADIA PHARMACEUTICALS
2022 · third_quarter · Q3
Rett Syndrome Research: H.R. 8236 Department of Defense Appropriations Act, 2023
Nursing Home Quality: S. 4659 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023; Neurology Research: S. 4661 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2023; Rett Syndrome Research: H.R. 8236, Department of Defense Appropriations Act, 2023
Drug pricing issues: H.R. 5376, Inflation Reduction Act of 2022; Neurology Research: S. 4661 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2023; Rett Syndrome Research: H.R. 8236 Department of Defense Appropriations Act, 2023; Parkinson's Plan: S. 4851, National Plan to End Parkinsons Act
ACADIA PHARMACEUTICALS via ACADIA PHARMACEUTICALS
2022 · second_quarter · Q2
Drug pricing issues
Medicare reform; Telehealth issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Cameron's Law (HR 14114)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOSECURE Act (HR 7085).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Drug Pricing Issues: H.R. 5376, Inflation Reduction Act of 2022; Nursing Home Quality: S. 4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023; Parkinson's Plan: S. 4851, National Plan to End Parkinsons Act; Six Protected Classes resolution: H. Res. 1390, Expressing support for the protection of Medicare part D's six protected classes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Drug pricing issues: H.R. 5376, Inflation Reduction Act of 2022; Neurology Research: S. 4661 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2023; Rett Syndrome Research: H.R. 8236 Department of Defense Appropriations Act, 2023; Parkinson's Plan: S. 4851, National Plan to End Parkinsons Act; Consolidated Appropriations Act, 2023: H.R.216
Rett Syndrome Research: H.R. 8236 Department of Defense Appropriations Act, 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Drug Pricing Issues: H.R. 5376, Inflation Reduction Act of 2022; Nursing Home Quality: S. 4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023; Parkinson's Plan: S. 4851, National Plan to End Parkinsons Act; Six Protected Classes resolution: H. Res. 1390, Expressing support for the protection of Medicare part D's six protected classes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE